This announcement is a separate document:
国信证券股份有限公司关于天士力医药集团股份有限公司重大资产出售之2021年度持续督导意见暨持续督导总结报告
Guoxin Securities Co., Ltd.'s 2021 Continued Supervision Opinions and Continued Supervision Summary Report on the Sale of Major Assets of Tianshili Pharmaceutical Group Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.